A double-blind trial of phenelzine in bulimia
- PMID: 3900362
- DOI: 10.1016/0022-3956(85)90058-5
A double-blind trial of phenelzine in bulimia
Abstract
Thirty normal weight women with bulimia completed a double-blind, placebo-controlled trial of phenelzine sulfate. The results demonstrate a significant therapeutic advantage for phenelzine over placebo. Preliminary data suggest that phenelzine may be of benefit even to non-depressed patients with bulimia.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical